EU denies blocking 3.1 million AstraZeneca shots to Australia

An Australian government source told Reuters that the EU had blocked 3.1 million shots. — Reuters pic
An Australian government source told Reuters that the EU had blocked 3.1 million shots. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.

CANBERRA, April 6 — The European Union today denied blocking shipments of 3.1 million doses of AstraZeneca’s Covid-19 vaccine to Australia as it steps up scrutiny of vaccine shipments to address EU shortages.

An Australian government source told Reuters that the EU had blocked 3.1 million shots and the country had little hope of getting the remaining 400,000 doses it has been promised on time.

The dispute underscores massive shortfalls of the AstraZeneca shot across the EU bloc and complicates Australia’s inoculation campaign, which is already 83 per cent behind its original schedule.

“We cannot confirm any new decision to block vaccine exports to Australia or to any other country,” a European Commission spokesman told a news conference.

A second spokeswoman said the bloc had rejected only one of a total of 491 Covid-19 vaccine export requests since it enhanced export transparency in late January, but added that seven requests were currently being reviewed - and therefore shipments were on hold until a decision was made.

She declined to say whether a new shipment to Australia was among those being reviewed.

The only rejected request has been so far a shipment of 250,000 doses to Australia earlier this year. As of March 24, the EU had exported 1 million doses to Australia.

With inoculation rollouts running far behind those of Britain and the United States, the EU tightened its oversight of vaccine exports last month, giving it greater scope to block shipments to countries with higher inoculation rates.

“They’ve blocked 3.1 million shots so far,” said the Australian government source, adding that it had only received 300,000 doses and a further 400,000 doses were scheduled to arrive by the end of April.

“We haven’t given up hope but we’ve stopped counting them in our expected supplies,” the source said. The person declined to be named because he is not authorised to talk about the matter.

Australia had until today only confirmed the block of 250,000 doses of the AstraZeneca doses from the EU, which Canberra said then would not delay its inoculation timetable.

An EU official said it was not responsible for AstraZeneca’s failure in upholding commitments to other countries, as the drug maker aims to deliver only 100 million doses to the bloc by the end of June out of 300 million it had pledged.

AstraZeneca did not immediately reply to a request for comment today.

It is unclear whether Australia plans to ask Britain or the United States to ship AstraZeneca doses.

Australian Prime Minister Scott Morrison said today the missing shipments were responsible for it not meeting its inoculation schedule.

“In early January, we anticipated we would have the 3.1 million vaccines. Those vaccines were not supplied to Australia,” Morrison told reporters in Canberra. “That is the reason.”

The AstraZeneca vaccine arriving from Europe were to underpin the early stages of Australia’s vaccine drive, supplementing 50 million shots of the vaccine that will be produced locally by CSL Ltd.

But the latest supply blockages leave Australia struggling to step up the pace of its vaccination drive, which started much later than some other countries due to low case numbers.

Australia has recorded just 909 coronavirus deaths since the pandemic began and said on Tuesday it would launch a quarantine and Covid-testing free travel bubble with New Zealand this month after effectively eradicating the virus by closing borders last year.

Its vaccine programme is now running well behind schedule, with only about 670,000 people inoculated against an initial target of 4 million by end-March.

While the government blamed the slow rollout for supply issues from Europe, Australian state governments have also complained about slower-than-expected distribution and a lack of certainty on supplies. — Reuters

Related Articles